921611-91-8

921611-91-8 Cyclohexanone, 2-[(1R)-1-(4-fluorophenyl)-2-nitroethyl]-, (2S)-

118270-86-3 2-Butenedioic acid (2E)-, dibutyl ester, polymer with ethenylbenzene, 2-hydroxyethyl 2-methyl-2-propenoate, methyl 2-methyl-2-propenoate and 2-methyl-2-propenoic acid

921612-18-2 1H-Pyrazole-3-carboxamide,1-(2,4-dichlorophenyl)-5-(4-fluorophenyl)-N-(hexahydrocyclopenta[c]pyrrol-2(1H)-yl)-4,5-dihydro-, (5R)-

118269-87-7 6-(2-chlorophenyl)-4-methyl-N-(2-morpholin-4-ylethyl)pyridazin-3-amine dihydrochloride

118269-78-6 4-methyl-6-phenyl-N-(2-pyrrolidin-1-ylethyl)pyridazin-3-amine dihydrochloride

118267-19-9 Oxacyclotetradecane,erythromycin deriv.

118269-74-2 N,N-dimethyl-N'-(4-methyl-6-phenylpyridazin-3-yl)ethane-1,2-diamine dihydrochloride

118269-90-2 4-methyl-6-(4-methylphenyl)-N-(2-morpholin-4-ylethyl)pyridazin-3-amine dihydrochloride

921611-69-0 Acetic acid, 2-(2-fluoro-6-nitrophenoxy)-, ethyl ester

118269-83-3 4-(2-chlorobenzyl)-N-(2-morpholin-4-ylethyl)-6-phenylpyridazin-3-amine dihydrochloride

118270-00-1 6-benzyl-4-methyl-N-(2-morpholin-4-ylethyl)pyridazin-3-amine dihydrochloride

118276-00-9 adenosine-2’,3’-monophosphorothioate,sp-/exoisomer

118269-81-1 4-benzyl-N-(2-morpholin-4-ylethyl)-6-phenylpyridazin-3-amine dihydrochloride

118270-30-7 4-morpholineethanamine, N-(4,6-diphenyl-3-pyridazinyl)-

118354-49-7 (1aS,1bS,5aS,9bR)-8-bromo-1a,1b,2,3,4,5,5a,9b-octahydrophenanthro[9,10-b]oxirene

921611-95-2 Thiourea, N-1-naphthalenyl-N'-[(2S)-2-pyrrolidinylmethyl]-

118269-86-6 6-(3-chlorophenyl)-4-methyl-N-(2-morpholin-4-ylethyl)pyridazin-3-amine dihydrochloride

118267-20-2 2-amino-5-phosphonoheptanoic acid

118267-80-4 2-Propen-1-one,1-(2-hydroxy-4,6-dimethoxyphenyl)-3-(2-methoxyphenyl)-

118276-99-6 2:PN: JP11313680 SEQID: 2 claimed protein